Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes

Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort... Diabetes Ther (2018) 9:1099–1111 https://doi.org/10.1007/s13300-018-0421-5 ORIGINAL RESEARCH Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes . . . Magaly Perez-Nieves Kristina S. Boye Jacek Kiljanski Dachung Cao Maureen J. Lage Received: January 8, 2018 / Published online: April 11, 2018 The Author(s) 2018 multivariable analyses were used to examine the ABSTRACT associations between adherence to basal insulin therapy and costs, resource utilization, and Introduction: This research compares costs, acute complications. resource utilization, and complications between Results: A total of 21,363 individuals were adherent and nonadherent patients over the included in the study. Three years after initiat- 3-year period post initiation on basal insulin ing therapy on basal insulin, patients who were therapy. adherent over time to basal insulin treatment Methods: The study utilized the US-based Tru- therapy (33.8% of patients) had significantly ven Health MarketScan Research Databases higher diabetes-related drug costs. However, from 2011 through 2015. Adults aged 18 years patients’ adherence was associated with signifi- or older and identified with type 2 diabetes cantly lower diabetes-related outpatient, acute (T2D) who initiated therapy on basal insulin in care, and total costs. Results for all-cause costs 2012 were http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetes Therapy Springer Journals

Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes

Download PDF
13 pages

Loading next page...
 
/lp/springer_journal/adherence-to-basal-insulin-therapy-among-people-with-type-2-diabetes-a-K3GmYfjF2m
Publisher
Springer Journals
Copyright
Copyright © 2018 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Diabetes; Cardiology; Endocrinology
ISSN
1869-6953
eISSN
1869-6961
DOI
10.1007/s13300-018-0421-5
Publisher site
See Article on Publisher Site

Abstract

Diabetes Ther (2018) 9:1099–1111 https://doi.org/10.1007/s13300-018-0421-5 ORIGINAL RESEARCH Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes . . . Magaly Perez-Nieves Kristina S. Boye Jacek Kiljanski Dachung Cao Maureen J. Lage Received: January 8, 2018 / Published online: April 11, 2018 The Author(s) 2018 multivariable analyses were used to examine the ABSTRACT associations between adherence to basal insulin therapy and costs, resource utilization, and Introduction: This research compares costs, acute complications. resource utilization, and complications between Results: A total of 21,363 individuals were adherent and nonadherent patients over the included in the study. Three years after initiat- 3-year period post initiation on basal insulin ing therapy on basal insulin, patients who were therapy. adherent over time to basal insulin treatment Methods: The study utilized the US-based Tru- therapy (33.8% of patients) had significantly ven Health MarketScan Research Databases higher diabetes-related drug costs. However, from 2011 through 2015. Adults aged 18 years patients’ adherence was associated with signifi- or older and identified with type 2 diabetes cantly lower diabetes-related outpatient, acute (T2D) who initiated therapy on basal insulin in care, and total costs. Results for all-cause costs 2012 were

Journal

Diabetes Therapy – Springer Journals

Published: Apr 11, 2018

References

  • Economic costs of diabetes in the US in 2012
  • Pharmacologic approaches to glycemic treatment
  • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group
    Turner, RC; Cull, CA; Frighi, V; Holman, RR
  • Basal insulin requirement is 30% o. f the total daily insulin dose in type 1 diabetic patients who use the insulin pump
    Kuroda, A; Kaneto, H; Yasuda, T
  • Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus
    Chien, M; Chen, Y; Hung, Y
  • Insulin therapy in people with type 2 diabetes: opportunities and challenges?
    Home, P; Riddle, M; Cefalu, WT
  • Initiating insulin in patients with type 2 diabetes
    Lau, ANC; Tang, T; Halapy, H; Thorpe, K; Yu, CHY
  • Correlates of insulin injection omission
    Peyrot, M; Rubin, RR; Kruger, DF; Travis, LB
  • Adherence to initiated basal insulin analog treatment in type 1 and 2 diabetes
    Westerbacka, J; Mihailov, H; Valle, T; Jääskeläinen, S; Kaukua, J
  • Cost sharing, adherence, and health outcomes in patients with diabetes
    Gibson, TB; Song, X; Alemayehu, B
  • Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually
    Jha, AK; Aubert, RE; Yao, J; Teagarden, JR; Epstein, RS
  • Medication adherence and improved outcomes among patients with type 2 diabetes
    Curtis, SE; Boye, KS; Lage, MJ; Garcia-Perez, L-E
  • Factors affecting sustained medication adherence and its impact on health care utilization in patients with diabetes
    Juarez, DT; Tan, C; Davis, J; Mau, M
  • Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes–an application of marginal structural models
    Yu, AP; Yu, YF; Nichol, MB
  • Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review
    Kennedy-Martin, T; Boye, KS; Peng, X
  • REMOVAL study team. A new perspective on metformin therapy in type 1 diabetes
    Livingstone, R; Boyle, JG; Petrie, JR
  • Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: a systematic review and meta-analysis
    Masri, D; Ghosh, S; Jaber, LA
  • Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes
    Buysman, E; Conner, C; Aagren, M; Bouchard, J; Liu, F
  • Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
    Ginde, A; Blanc, P; Lieberman, R; Camargo, C
  • Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
    Quan, H; Sundararajan, V; Halfon, P
  • Validating the adapted Diabetes Complications Severity Index in claims data
    Chang, H-Y; Weiner, JP; Richards, TM; Bleich, SN; Segal, JB
  • Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment
    Ayyagari, R; Wei, W; Cheng, D; Pan, C; Signorovitch, J; Wu, EQ
  • Association of depression and anxiety with diabetes mellitus type 2 concerning some sociological factors
    Palizgir, M; Bakhtiari, M; Esteghamati, A
  • Estimating decision-relevant comparative effects using instrumental variables
    Basu, A
  • Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes
    Encinosa, WE; Bernard, D; Dor, A
  • Statistical models for the analysis of skewed healthcare cost data: a simulation study
    Malehi, AS; Pourmotahari, F; Angali, KA
  • Does medication adherence lead to lower healthcare expenses for patients with diabetes?
    Cheng, S-H; Chen, C-C; Tseng, C-H
  • Basal insulin persistence, associated factors, and outcomes after treatment initiation: a retrospective database study among people with Type 2 diabetes mellitus in Japan
    Hadjiyianni, I; Desai, U; Suzuki, S
  • Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US
    Perez-Nieves, M; Kabul, S; Desai, U
  • Estimating the impact of oral diabetes medication adherence on medical costs in VA
    Wong, ES; Bryson, CL; Hebert, PL; Liu, C-F
  • A review of diabetes treatment adherence and the association with clinical and economic outcomes
    Asche, C; LaFleur, J; Conner, C
  • The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study
    Han, E; Suh, D-C; Lee, S-M; Jang, S
  • Fewer emergency readmissions and better quality of life for older adults at risk of hospital readmission: a randomized controlled trial to determine the effectiveness of a 24-week exercise and telephone follow-up program
    Courtney, M; Edwards, H; Chang, A; Parker, A; Finlayson, K; Hamilton, K
  • Hospital epidemiology and infection control in acute-care settings
    Sydnor, ERM; Perl, TM
  • Risk of infection following a visit to the emergency department: a cohort study
    Quach, C; McArthur, M; McGeer, A
  • Results of the medications at transitions and clinical handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission
    Gleason, KM; McDaniel, MR; Feinglass, J
  • Human factors and error prevention in emergency medicine
    Bleetman, A; Sanusi, S; Dale, T; Brace, S
  • Hyperglycemia and the pathobiology of diabetic complications
    Aronson, D
  • Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study
    Haukka, J; Hoti, F; Erästö, P; Saukkonen, T; Mäkimattila, S; Korhonen, P
  • Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
    Whitmer, RA; Karter, AJ; Yaffe, K; Quesenberry, CP; Selby, JV
  • Adherence to insulin pen therapy is associated with reduction in healthcare costs among patients with type 2 diabetes mellitus
    Chandran, A; Bonafede, MK; Nigam, S; Saltiel-Berzin, R; Hirsch, LJ; Lahue, BJ
  • Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus
    Cobden, D; Lee, WC; Balu, A; Joshi, V; Pashos, CL
  • The association of insulin medication possession ratio, use of insulin glargine, and health benefit costs in employees and spouses with type 2 diabetes
    Kleinman, NL; Schaneman, JL; Lynch, WD
  • Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement
    Egede, LE; Gebreqziabher, M; Dismuke, CE
  • Adherence and health care costs
    Iuga, AO; McGuire, MJ
  • Predictors of medication adherence postdischarge: the impact of patient age, insurance status, and prior adherence
    Cohen, MJ; Shaykevich, S; Cawthon, C; Kripalani, S; Paasche-Orlow, MK; Schnipper, JL